In Reversal, Helicos Appeals EPO Decision to Maintain lllumina Patent

Helicos ended its opposition to the IP last summer, and in October 2008, the EPO maintained the patent in an amended form. But in an apparent reversal, Helicos in January filed a notice of appeal of the EPO's decision.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories